Skip to content

The characteristics of gut microbiota and biological markers for therapeutic effect in drug-free adolescents with obsessive-compulsive disorder

The characteristics of gut microbiota and biological markers for therapeutic effect in drug-free adolescents with obsessive-compulsive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095265
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-01-04
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Sponsors

Shandong Daizhuang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patient Group: (1) Meet the DSM-5 diagnostic criteria for obsessive-compulsive disorder through structured clinical interview (SCID-V); (2) Age between 10 to 18 years old; (3) Patients voluntarily participate in the study, have obtained family consent, and have signed an informed consent form; (4) Understand written language and are able to complete questionnaires; (5) Score of >=16 on the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS); (6) Han ethnicity, right-handed; (7) Have not taken any medication for the treatment of obsessive-compulsive disorder for at least 8 weeks prior to enrollment. Healthy Control Group: (1) Age between 10 to 18 years old; gender-matched with the patient group; (2) Voluntarily participate in the study, have obtained family consent, and have signed an informed consent form; (3) Understand written language and are able to complete questionnaires; (4) Han ethnicity, right-handed.

Exclusion criteria

Exclusion criteria: Patient Group: (1) History of substance dependence; history of mental disorders that meet the SCID Axis I diagnostic criteria; history of brain trauma, epilepsy, or other organic brain diseases; (2) Laboratory tests indicate other severe physical diseases and metabolic disorders; (3) Use of probiotics, antibiotics, nonsteroidal anti-inflammatory drugs, or steroids within the last 8 weeks; (4) Pregnant or breastfeeding patients; (5) Comorbidities including diabetes, endocrine diseases (hyperthyroidism, Hashimoto's thyroiditis), cardiovascular and cerebrovascular diseases (hyperlipidemia, stroke), autoimmune diseases (inflammatory bowel disease, irritable bowel syndrome, celiac disease, rheumatoid arthritis, Sjögren's syndrome), history of gastrointestinal surgery, or history of gastrointestinal infection within the last 3 months (appendectomy or cholecystectomy excluded); (6) Extreme diets, such as vegetarianism; (7) Significant changes in dietary structure or lifestyle within the last month before enrollment; (8) Color blindness. Healthy Control Group: (1) History of substance dependence; history of any mental disorders that meet the SCID Axis I or II diagnostic criteria; history of brain trauma, epilepsy, or other organic brain diseases; (2) Positive family history of mental illness in two generations and three degrees; (3) History of taking antipsychotic or antidepressant medications; use of probiotics, antibiotics, nonsteroidal anti-inflammatory drugs, or steroids within the last 8 weeks; (4) Comorbidities including diabetes, endocrine diseases (hyperthyroidism, Hashimoto's thyroiditis), cardiovascular and cerebrovascular diseases (hyperlipidemia, stroke), autoimmune diseases (inflammatory bowel disease, irritable bowel syndrome, celiac disease, rheumatoid arthritis, Sjögren's syndrome), history of gastrointestinal surgery, or history of gastrointestinal infection within the last 3 months (appendectomy or cholecystectomy excluded); (5) Extreme diets, such as vegetarianism; (6) Significant changes in dietary structure or lifestyle within the last month before enrollment; (7) Pregnant or breastfeeding; (8) Color blindness.

Design outcomes

Primary

MeasureTime frame
The characteristics of the gut microbiota in adolescents with obsessive-compulsive disorder;Biological markers related to the efficacy of treatments for obsessive-compulsive disorder in adolescents;

Secondary

MeasureTime frame
The Mechanism of the Microbiota-Gut-Brain Axis in Adolescent obsessive-compulsive disorder;

Countries

China

Contacts

Public ContactKun Li

Shandong Daizhuang Hospital

likunyjs@163.com+86 195 5370 0077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026